Gilead Settles HIV Drug Lawsuit Over Patent on Truvada and Descovy
Settlement gives Gilead license to continue selling the medications as preventative measures for HIV.
Tag Archives: HIV
-
-
Gilead Claims Twice-Annual Injection Better At Preventing HIV Than Daily PrEP Pill
Clinical trial results come as Gilead continues to face lawsuits over side effects of some of its older HIV drugs, claiming the manufacturer delayed introduction of safer formulations to extend it's monopoly over the HIV market.
-
U.S. Government Files Appeal Over Gilead Truvada, Descovy HIV Drug Patents
Appeal comes as Gilead continues to face thousands of HIV drug lawsuits in California state court, alleging that users experienced bone fractures and kidney injuries due to Truvada and other TDF-based medications.
-
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
HIV drug settlement does not resolve the Truvada lawsuits, Atripla lawsuits, Stribild lawsits, Viread lawsuits and Complera lawsuits pending in California state court, where tens of thousands of additional claims are filed.
-
TDF Lawsuit Filed Against Gilead Over Toxic Side Effects of Truvada, Atripla, Other HIV Drugs
In addition to claims filed in federal court, Gilead faces about 24,000 TDF lawsuits in California state court, each raising similar allegations that the drug maker withheld a safer version of its HIV drugs.
-
Lawsuits Over Truvada, Other TDF-Based HIV Drugs Cleared To Move Forward By Appeals Court
California judges determined Truvada lawsuits, Atripla lawsuits, Stribild lawsits, Viread lawsuits and Complera lawsuits can be pursued by users who developed kidney damage, bone fractures and other side effects from the HIV drugs.
-
HIV May Cause Some Cases of Stevens-Johnson Syndrome Without Drug Interaction: Study
Researchers published a case report which identified a woman who developed Stevens-Johnson Syndrome caused by HIV, as opposed to being the result of a reaction from taking a new medication.
-
HIV Drug Descovy May Increase Risk of High Blood Pressure: Study
Researchers warn that the hypertension risks linked to Descovy appear to increase with the age of the patient.
-
Appeals Court Weighs Gilead Challenge to Lawsuits Over Delaying HIV Drug Development
Gilead claims it had no duty to develop safer TAF-based HIV drugs to replace its older TDF-based medications, including Truvada, Viread, Stribild and others, which have been linked to bone fractures, kidney injuries and other side effects.
-
U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention
Properly identifying patients at higher risk of transmission increases the benefits of prescribing certain HIV drugs as prophylactics, researchers determined.
